Recruitment for the FAIR PARK II study is now closed: The last patient has been enrolled on December 5th 2019
The FAIR-PARK II 6h annual meeting was held virtually on 22nd April 2021
The FAIR-PARK II 5th annual meeting was held in Paris, France on 26th June 2019.
The FAIR-PARK II 4th annual meeting was held in Lisbon, Portugal on 15th and 16th June 2018.
The FAIR-PARK II 3rd annual meeting was held in Amsterdam, Netherlands on 26th and 27th June 2017.
The FAIR-PARK II 2nd annual meeting was held in Berlin, Germany on 23-24 June 2016.
The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015.
Recruitment for the FAIR PARK II study is now open: The first patient has been enrolled in Lille's hospital on February 9th 2016
The final list of European expert centres for the clinical trial is available since October 2015.
The final version of the protocol, as released by competent authorities and ethic national committees is available since january 2016
Patient Recruitment Countdown
16th December 2019
Patients to be recruited
0
Patients recruited
372
The recruitment is now closed
Daniela Berg - Eberhard Karls Universitaet Tuebingen |
|
|
Nicola Pavese - University of Newcastle upon Tyne |
Jacques Demotes - European Clinical Research Infrastructure Network |
|
David Devos - Centre Hospitalier Regional et Universitaire de Lille |
|
Richard Dodel - Philipps Universitat Marburg |
|
Dominique Deplanque - Centre Hospitalier Regional et Universitaire de Lille |
|
Joaquim Ferreria - Instituto de Medicina Molecular |
|
Gian Luca Forni - Ospedia Galliera |
|
Holm Graessner - Eberhard Karls Universitaet Tuebingen |
|
Werner Poewe - Medizinische Universitat Innsbruck |
|
Olivier Rascol - Inserm F-CRIN |
|
Evžen Růžička - Univerzita Karlova v Praze |
|
Delphine Smagghe - INSERM - Transfert SA |
|
Eduardo Tolosa - Fundació privada Clínic per a la Recerca Biomèdica |
|
JC Corvol - Inserm |
|
Pauline Guyon - CHRUL |
|
Bart Post - RUNMC |
Fair Park II is a collaborative research project funded in part through the EU's Horizon 2020 research and innovation programme. Find out here who is involved and how the project is managed by the executive committee, the general assembly and various specialized boards of governance.
The Consortium and the Partners
Independent Data and Safety Monitoring Board
Here is the management structure of Fair Park II:
Professor Werner Poewe is Professor of Neurology and Director of the Department of Neurology at Medical University Innsbruck, Austria. Professor Poewe’s main research interests are in the field of Parkinson’s Disease and Movement Disorders where he has authored and co-authored more than 550 original articles and reviews. Prof. Poewe served as President of the International Movement Disorder Society from 2000 through 2002 and as chair of the MDS European Section from 2011-2013 and as President of the Austrian Society of Neurology from 2002 to 2004 as well as President of the Austrian Parkinson’s Disease Society from 1996-2009. Werner Poewe is Corresponding Member of the American Neurological Assocation and the French Neurological Society and Honorary Member of the German Neurological Society as well as the Japanese Neurological Society . In 1995 he received the Walther-Birkmayer-Prize of the Austrian PD Society and in 2006 the Dingebauer Prize of the German Neurological Society.
Find out more about Fair Park II from Prof David Devos, the project coordinator
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
People
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon [email protected]
Senior Project Manager (IT): Delphine Smagghe [email protected]
Project Manager (IT): Stephanie Le Naour [email protected]
Addresses
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France